Chatham-Kent police arrested four people and seized approximately $1,400 worth of suspected methamphetamine and oxycodone pills during a drug bust at a Wallace…
TORONTO About 20 months after the federal government unveiled a program aimed at erasing Canadians’ prohibition-era records for cannabis possession, fewer than 400 people have successfully been pardoned, the Parole Board of Canada said. As of March 1, officials have granted 395 record suspensions, or pardons, under the program, or more or less one per working day since it started on August 1, 2019. Another 251 have been rejected “due to ineligibility or incompleteness,” the Parole Board of Canada said. Canadians with criminal records, including those related to cannabis, have always been able to ask for pardons if they were eligible (generally, the less serious the crime, the sooner you can ask to be pardoned). The process costs $644 to apply.
Four people charged after drug bust in Wallaceburg chathamdailynews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chathamdailynews.ca Daily Mail and Mail on Sunday newspapers.
Article content
A Calgary man has been charged in relation to an international trafficking scheme to export methamphetamine from Alberta to Australia following a months-long investigation.
The Integrated Border Enforcement Team (IBET) arrested and charged the 31-year-old man with multiple drug trafficking offences after seizing about three kilograms of methamphetamine that was being shipped to Australia, according to a release from RCMP.
We apologize, but this video has failed to load.
Try refreshing your browser, or Calgary man charged in plot to smuggle methamphetamine to Australia Back to video
Canada Border Services Agency (CBSA) officers located two boxes of crystalline powder later determined to be meth being shipped to Australia in September 2020. The investigation was passed to IBET, a federal policing unit based in Calgary and Edmonton with members of the local RCMP, CBSA and Calgary police.
Core One Labs Inc.: Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FSE:LD62)(WKN:A2P8K3) (the
Company ) is pleased to announce that in collaboration with Ketamine Infusions Centers of Texas LLC (KICT) it is exploring a development program for N-dimethyltryptamine (DMT) assisted psychotherapy to address anxiety and depression.
In December 2020, the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom (UK) approved the world s first clinical trial testing the efficacy and safety of DMT as a treatment for depression. The first phase of the study (Phase I) commenced in January 2021, with proof of concept Phase IIa expected to follow shortly thereafter. The trial is being conducted by Small Pharma Ltd., a neuropharmaceutical company, working in collaboration with the Centre for Psychedelic Research at Imperial College London